2009-06-05
12:46:12
A probe by the ombudsman is underway into Ontario's limited funding of a drug for colon cancer patients.
Andre Marin says he's reviewing the Ministry of Health and Long-Term Care's policies for Avastin.
Under current rules, the funding is limited to 16 two-week cycles, regardless of how a patient responds to treatment.
